Principal Financial Group’s PMV Pharmaceuticals PMVP Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q2 | – | Sell |
-14,180
| Closed | -$24.1K | – | 2434 |
|
2024
Q1 | $24.1K | Sell |
14,180
-1,436
| -9% | -$2.44K | ﹤0.01% | 2395 |
|
2023
Q4 | $48.4K | Sell |
15,616
-903,526
| -98% | -$2.8M | ﹤0.01% | 2333 |
|
2023
Q3 | $5.64M | Sell |
919,142
-7,593
| -0.8% | -$46.6K | ﹤0.01% | 1490 |
|
2023
Q2 | $5.8M | Buy |
926,735
+8,850
| +1% | +$55.4K | ﹤0.01% | 1477 |
|
2023
Q1 | $4.38M | Buy |
917,885
+22,019
| +2% | +$105K | ﹤0.01% | 1577 |
|
2022
Q4 | $7.79M | Sell |
895,866
-52,010
| -5% | -$452K | 0.01% | 1373 |
|
2022
Q3 | $11.3M | Buy |
947,876
+126,644
| +15% | +$1.51M | 0.01% | 1121 |
|
2022
Q2 | $11.7M | Buy |
821,232
+202,306
| +33% | +$2.88M | 0.01% | 1165 |
|
2022
Q1 | $12.9M | Buy |
618,926
+21,964
| +4% | +$457K | 0.01% | 1232 |
|
2021
Q4 | $13.8M | Buy |
596,962
+107,027
| +22% | +$2.47M | 0.01% | 1214 |
|
2021
Q3 | $14.6M | Buy |
489,935
+28,022
| +6% | +$835K | 0.01% | 1176 |
|
2021
Q2 | $15.8M | Buy |
461,913
+263,491
| +133% | +$9M | 0.01% | 1159 |
|
2021
Q1 | $6.53M | Buy |
198,422
+1,967
| +1% | +$64.7K | ﹤0.01% | 1572 |
|
2020
Q4 | $12.1M | Sell |
196,455
-4,345
| -2% | -$267K | 0.01% | 1117 |
|
2020
Q3 | $7.13M | Buy |
+200,800
| New | +$7.13M | 0.01% | 1280 |
|